Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome. (Q51493311)
Jump to navigation
Jump to search
scientific article published in August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome. |
scientific article published in August 2006 |
Statements
1 reference
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome. (English)
1 reference
1 reference
1 reference
1 reference
Ragonesi PD
1 reference
Ciccarelli L
1 reference
Piccinni MN
1 reference
Pricolo F
1 reference
Salvadeo SA
1 reference
Montagna L
1 reference
Gravina A
1 reference
Ferrari I
1 reference
Paniga S
1 reference
1 August 2006
1 reference
31
1 reference
375-383
1 reference
4
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference